OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
EBV is a B cell tropic, oncogenic gamma-herpes virus that infects more than 90% of the adult population worldwide. In immunosuppressed individuals, EBV may cause a wide spectrum of pathologies, ranging from lymphoproliferation to frank lymphoma.
EBV-driven B cell expansion is a metabolically demanding process. Targeting metabolic vulnerabilities of B cells en route to virus-driven transformation may thus offer therapeutic opportunities.
In my seminar, I will present emerging data on EBV-driven metabolic changes required for latent infection of B cells. Molecular metabolic aspects, preclinical models and clinical data will be discussed.
